InvestorsHub Logo
Followers 7
Posts 572
Boards Moderated 0
Alias Born 04/21/2019

Re: rafunrafun post# 191284

Monday, 05/13/2019 2:38:30 PM

Monday, May 13, 2019 2:38:30 PM

Post# of 430576
Problem now is priority review is likely to only get the share price back to the $18’s. Just don’t think there is any serious interest from big pharma until fda approves the expanded label. And now the market is in free fall for a while, or at least it seems. Good luck everyone.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News